Dienstag, 24. September 2019, Berlin, The European Medical Cannabis Conference

Von 24. September 2019 - 9:00
Bis 25. September 2019 - 16:00
Karte anzeigen
The Cannabis Society, with support from Dentons and FTI Consulting, has put together a distinguished two-day medical cannabis conference. Come join us and hear presentations and panels from researchers, lawmakers, regulatory experts, economists, and industry experts discuss the current state of medical cannabis science, cannabis application, laws and market trends within the European Union and abroad.
The Cannabis Society (TCS) is an organization focused on progressing the medical cannabis industry in Europe. TCS runs highly-curated, invite-only, professional-only conferences that bring together top cannabis researchers, medical professionals, industry executives, investors and service providers.
TCS is a global organization hosting conferences and events in markets including Europe, North America, South America, Israel, and Australia.


Boris, Blatnik, CEO, KannaSwiss AG
Boris serves as CEO of KannaSwiss. He joined the team January of 2017 and has been instrumental in the rebranding and business development of the company. Prior to KannaSwiss Boris served as CSO and Co-founder of Numbridge Inc. from 2009 until 2016. Numbridge was a telecommunication app that helped people communicate over the GSM network. Boris served as CEO & Co-founder of Atlas Commercial Holdings from 2004 until 2009. Atlas established an interlocking network of global business alliances and partnerships to provide customized solutions that enable governments and local businesses in emerging markets to stabilize and upgrade their basic infrastructures. Formerly he was Founder & President of V Karting, an integrated go-kart facility with conference rooms, restaurant, and entertainment/game space. His experiences range from construction to telecommunications to natural resource consulting working with such companies as MAN Ferrostaal and Petrobras.
Boris earned his A-levels from Aiglon College in Villars, Switzerland and then attended American University in Washington, DC. Born in Caracas, Venezuela, Boris was raised in Switzerland and moved to the U.S. to attend university. He is fluent in English, Spanish, French, German, Italian, and Portuguese.

Patricia Frye M.D, Chief Medical Officer, Hello MD
Patricia Frye M.D.is Chief Medical Officer of HelloMD and began her journey with medicinal cannabis as the first evaluating physician on the company’s digital healthcare platform. She is professionally certified by the University of Vermont School of Medicine in Cannabis Science and Medicine and serves on the board of the Cannabis Trade Federation and the Society of Cannabis Clinicians.
As an adjunct faculty member in Cannabis Medicine at the University of Maryland School of Pharmacy, she lectures nationally, educating medical providers, patient groups, policy makers, and government agencies on the medical benefits of cannabis. In 2018 she authored and published the book “The Medical Marijuana Guide: Cannabis and Your Health”.

Mehr anzeigen
She is also the founder and medical director of Takoma Park Integrative Care. Her practice focuses on the role of cannabis in the management of chronic pain, inflammation, autoimmunity, neurodegenerative disorders, autism, insomnia, and psychiatric conditions and over the years has evaluated and advised thousands of patients on the use of medical cannabis. Dr. Frye works closely with patients residing in Maryland, Virginia, and Washington, DC and with referring clinicians, including those at the University of Maryland, Johns Hopkins University, and the Children’s National Medical Center, to develop sound treatment plans that are based on both observational and scientific evidence.

Tjalling Erkelens, Founder & CEO, Bedrocan
Tjalling Erkelens (1956) is the founder of Bedrocan and currently holds the position of CEO / chairman of the board. Back in 1984 he started Bedrocan in the Netherlands together with his brother in law Freerk Bruining, focussing on indoor production of vegetables and herbs. Tjalling is strongly committed to maintain these family business roots especially now Bedrocan continues to grow.
The cannabis plant came into the company back in 1992 for the first time. Since 2003 Bedrocan provides standardised cannabis of pharmaceutical quality to the Dutch government. It’s the oldest legal company in the world providing several, chemically different cannabis varieties to be used by patients on doctor’s prescription and as a raw material for the pharmaceutical industry (API).
During these past 26 years, Tjalling has developed and standardised unique methods of producing cannabis to pharmaceutical standards to a level achieved by no other company until today. His strong commitment to product quality resulted in the Dutch Bedrocan production facilities being approved for GMP/API (Good Manufacturing Practice/Active Pharmaceutical Ingredients) by the Dutch Health Authorities in 2017.

Dr. Robert Pawinski, Chief Medical Officer, Althea
Dr Robert Pawinski is an experienced Pharmaceutical Physician in both academia and industry. Robert has led a clinical, epidemiology and Health economics research team where he was principal investigator in multiple trials, as well as working as a clinician in the private and public sector in the UK and abroad. Robert has extensive senior experience in two of the Big-Five Global Pharma, and small and mid-sized pharmaceutical companies in a leadership role as QPPV, EU Medical Director. Robert also has experience working at a senior government level with bodies like the WHO, NICE, the MHRA and EMA. Dr Pawinski also has deep knowledge of the EU and Emerging markets from an access and clinical trial perspective, with over 27 peer review publications on pain and infectious diseases which include the Lancet and JAIDS.

Rick Brar, CEO & Chairman at Brains Bioceutical Corp.
Rick Brar was most recently Co-Founder and Former CEO of Zenabis Global Inc., one of the leading Canadian LPs with operations in both medical and recreational cannabis. Under Brar’s leadership, Zenabis grew from a privately held LP to a public company with a market capitalization close to CAD900m during his tenure as CEO. Brar is currently the CEO & Chairman of Brains Bioceutical Corp., a global manufacturer and distributor of Cannabinoid APIs.
Brar plays an active role in the Cannabis regulatory environment and he has worked to improve access globally, from being a part of the ACPMR Stakeholder Roundtable for Bill C45, held by Health Canada, to holding positions with the Centre for Medical Cannabis (CMC) and the CDPRG.
He has successfully launched multiple entrepreneurial ventures in North America, South America, Europe and Asia. He is an experienced leader in the cannabis, nutraceuticals, beverage, agriculture, and land development industries.

Dr. Jonas Vanderzwan, MD, CCFP
Canadian physician with 15 years of primary care experience, and extensive experience in the use of medical cannabis. As a lead physician of a local cannabis clinic, he has been involved in the assessment and care of approximately 1500 patients, using cannabis as a treatment in a wide range of clinical conditions. As an early adopter of cannabis as a therapeutic agent, he has had the opportunity to travel the World, educating other medical professionals and patient groups on both the use and potential benefits of cannabis. Dr. Vanderzwan is an active consultant in the medical cannabis environment, having worked with both private and public players in the space, and since 2018 has been serving as Medical Director, and Chair of the Medical Advisory Board, for a Health Canada approved Licensed Producer of medical cannabis. In addition to ongoing membership in several international cannabinoid medicine organizations, Dr. Vanderzwan has most recently been appointed Vice-Chair of the Ontario Medical Association’s medical cannabis interest group.

Dr. Adam Norris, MD, DABFM, CCFP
Adam Norris has been working as a physician in Brantford, Ontario for the past 5 years. He completed his undergraduate studies at Dalhousie University in Neuroscience. Adam received his medical degree from Ross University and did a Family medicine residency at Northeastern University School of Medicine in Ohio. He is board-certified in both Canada and the USA.Dr. Norris is a Family Physician and Medical Director of GreenDot Medical Center, Cannabinoid Clinic. He is currently Assistant Clinical Professor for Faculty of Family Medicine and Associate Professor at the MGD Centre for Medicinal Cannabis Research. This past year, he has taken a role as a consultant for Addiction Medicine at Brantford General Hospital.

Peter Homberg, Partner, Dentons
Peter Homberg is a partner in the Dentons Berlin office. He focuses on life sciences, IP, corporate law and M&A transactions in the life sciences and high-tech sector as well as in R&D and cooperation agreements, cross-border IP licensing and IP strategies. Furthermore, he has extensive experience providing legal advice on compliance issues. Additionally, he is the head of the European Cannabis sector group. Peter advises inter alia companies in the pharmaceutical, diagnostics, biotechnology, medical device, and medical cannabis industries—from startups to large publicly listed companies. Furthermore, he has broad transactional experience in Southeast Asia. Peter is a member of the Licensing Executive Society (LES), the German Association for Intellectual Property and Copyright (GRUR), the German Institution for Arbitration (DIS) as well as the Pharma-Lizenz-Club Deutschland e.V. He regularly holds lectures at seminars and conferences. He is the author of numerous professional articles and other publications regarding corporate or IP law in the field of life sciences.

Melissa Sturgess, Chief Executive Officer of Ananda Developments Plc
Melissa Sturgess holds a BSc and an MBA and has more than 20 years of experience as a director of UK and Australian Stock Exchange quoted companies, mainly involved in the acquisition, structuring and financing of natural resources deals across Africa. Miss Sturgess commenced her career in Australia as a member of the Executive Committee of Aquarius Platinum Limited, one of the first Australia/UK dual-listed companies and a miner of platinum in South Africa and Zimbabwe. She was also founding director of Sylvania Resources Limited and a number of other companies operating in the metals and mining sector throughout Africa and listed on the AIM Market in London. Miss Sturgess relocated to London in 2006 and during her career has raised significant amounts of capital. She was a key driver in the successful recapitalization of Messaging International plc during 2016 which subsequently changed its name to SigmaRoc Plc, acquired a building materials business via a reverse takeover and raised £50 million from a range of investors in the Channel Islands and the UK. Miss Sturgess’ interest in the cannabis sector started in 2017 with a trip to Israel to review the Medicinal Cannabis research that is happening in that country. She subsequently founded Ananda Developments to invest in the space and is its largest shareholder.

Golan Bitton, CEO & Co-Founder, Univo Pharmaceuticals
Golan has 22 years of managerial experience in the Israeli Ministry of Defense. He Implemented and managed multi-million dollar projects for the Israeli Government. Golan holds a B.A. in Economics from Max Stern Academic College and Computer Engineering from Negev University.



If you are an established national or international company and are looking to learn more about the cannabis space, please reach out to manager@thecannabissociety.org for more information.
***More information about the Cannabis Society here.

The European Medical Cannabis Conference, Berlin ereignis

Investor Readiness Session Berlin

Investor Readiness Session Berlin

Mittwoch 30. September 2020
Investor Readiness Session Berlin

Investor Readiness Session Berlin

Mittwoch 07. Oktober 2020
Investor Readiness Session Berlin
Mittwoch 21. Oktober 2020
Investor Readiness Session Berlin
Mittwoch 28. Oktober 2020
Investor Readiness Session Berlin
Mittwoch 04. November 2020
Investor Readiness Session Berlin
Mittwoch 18. November 2020
Investor Readiness Session Berlin
Mittwoch 25. November 2020
Investor Readiness Session Berlin
Mittwoch 02. Dezember 2020
Investor Readiness Session Berlin
Mittwoch 16. Dezember 2020
Christmas Calendar
Sonntag 01. Dezember 2019
Weitere interessante veranstaltungen
Holen event empfehlungen basierend auf Ihre Facebook geschmack. Hol es dir jetzt!Zeigen sie mir die passenden veranstaltungen für michJetzt nicht